Security National Bank Acquires 672 Shares of Stryker Corporation (NYSE:SYK)

Security National Bank grew its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 2.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,481 shares of the medical technology company's stock after acquiring an additional 672 shares during the period. Stryker comprises approximately 1.9% of Security National Bank's holdings, making the stock its 12th largest position. Security National Bank's holdings in Stryker were worth $9,858,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in shares of Stryker by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 32,698,828 shares of the medical technology company's stock worth $11,773,213,000 after purchasing an additional 252,188 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Stryker by 0.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 11,109,722 shares of the medical technology company's stock worth $4,000,056,000 after buying an additional 54,693 shares in the last quarter. FMR LLC raised its holdings in Stryker by 10.0% during the fourth quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock valued at $2,892,946,000 after acquiring an additional 727,850 shares during the period. Geode Capital Management LLC lifted its position in shares of Stryker by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 7,073,562 shares of the medical technology company's stock valued at $2,539,033,000 after acquiring an additional 168,436 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Stryker in the fourth quarter worth about $1,710,744,000. 77.09% of the stock is owned by institutional investors.

Stryker Trading Up 1.0%

Shares of SYK stock traded up $4.07 during trading hours on Friday, reaching $394.47. 223,973 shares of the stock were exchanged, compared to its average volume of 1,336,595. The firm has a market capitalization of $150.57 billion, a price-to-earnings ratio of 53.30, a price-to-earnings-growth ratio of 2.96 and a beta of 0.91. Stryker Corporation has a 12-month low of $314.93 and a 12-month high of $406.19. The company's 50-day moving average price is $378.06 and its 200-day moving average price is $375.38. The company has a current ratio of 1.64, a quick ratio of 1.00 and a debt-to-equity ratio of 0.69.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. During the same period in the prior year, the business posted $2.50 earnings per share. The company's revenue for the quarter was up 11.9% on a year-over-year basis. As a group, equities analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.85%. Stryker's dividend payout ratio (DPR) is 45.41%.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SYK. Wall Street Zen raised Stryker from a "hold" rating to a "buy" rating in a report on Saturday, June 14th. Sanford C. Bernstein set a $450.00 target price on shares of Stryker in a report on Monday, May 5th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Truist Financial boosted their price target on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research note on Monday, May 5th. Finally, Roth Mkm raised their price objective on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research report on Friday, May 2nd. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.